Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZLAB · against 337 other Healthcare companies of similar size
Ranked #130 of 338 · scores higher than 60% of peers
Bars: peers in each 10-point band of the growth score41 peers with a growth score of 60–69, including ZLAB · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
| Metric | ZLAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 337 reported | 5.1% | 6.7% | 45% | 33% | |
| Earnings per share growthHigher is better · 198 reported | Not reported | 9.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 329 reported | 21.3% | 7.4% | 80% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 130 | 12.9B HKD (≈$1.7B) | 64 | 83 | |
| 130 | 2.7B CAD (≈$2.0B) | 64 | 54 | |
| 130 | 4.0B USD | 64 | 46 | |
| 130 | 142.9B INR (≈$1.7B) | 64 | 64 | |
| 130 | 2.5B USD | 64 | 31 | |
| 136 | 19.0B CNY (≈$2.7B) | 63 | 55 | |
| 136 | 10.8B SAR (≈$2.9B) | 63 | 68 | |
| 136 | 10.8B CNY (≈$1.5B) | 63 | 80 | |
| 136 | 11.1B BRL (≈$2.0B) | 63 | 60 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score